Hyperfine logo

HyperfineNASDAQ: HYPR

Profile

Sector:

Healthcare

Country:

United States

IPO:

28 January 2021

Next earnings report:

08 November 2024

Last dividends:

N/A

Next dividends:

N/A
$70.44 M
-89%vs. 3y high
39%vs. sector
-vs. 3y high
-vs. sector
-62%vs. 3y high
42%vs. sector
-98%vs. 3y high
64%vs. sector

Price

after hours | Fri, 01 Nov 2024 20:07:32 GMT
$0.97-$0.02(-1.98%)

Dividend

No data over the past 3 years
$3.63 M$3.30 M
$3.63 M-$10.16 M

Analysts recommendations

Institutional Ownership

HYPR Latest News

HYPR Achieves Positive Swoop System Data for ECMO: Stock to Rise?
zacks.com02 October 2024 Sentiment: POSITIVE

Hyperfine announces a publication on using the Swoop system for patients on ECMO support. The study showed the safety of using an ultra-low-field portable brain MRI on patients undergoing ECMO.

Favorable Data on Swoop Portable MRI Likely to Support Hyperfine Stock
zacks.com26 September 2024 Sentiment: POSITIVE

Compared to conventional MRI, which takes an average of 27.7 hours, the Swoop system of HYPR operates with a median time-to-scan of 2.5 hours.

Researchers to Monitor Astronaut Brain Health Using Images Acquired with the Hyperfine, Inc. Swoop® Portable MR Imaging® System
businesswire.com11 September 2024 Sentiment: POSITIVE

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced a collaboration with the Medical University of South Carolina to assess the brains of astronauts before and after embarking on the Polaris Dawn mission. Researchers will utilize the Swoop® Portable MR Imaging® system at a SpaceX facility in.

Hyperfine, Inc. (HYPR) Q2 2024 Earnings Call Transcript
seekingalpha.com09 August 2024 Sentiment: NEUTRAL

Hyperfine, Inc. (NASDAQ:HYPR ) Q2 2024 Earnings Call August 8, 2024 4:30 PM ET Company Participants Marissa Bych - Investor Relations Maria Sainz - President and Chief Executive Officer Brett Hale - Chief Administrative Officer and Chief Financial Officer Conference Call Participants Yuan Zhi - B. Riley Operator Good afternoon, and welcome to Hyperfine's Second Quarter 2024 Earnings Conference Call.

Hyperfine, Inc. (HYPR) Reports Q2 Loss, Tops Revenue Estimates
zacks.com08 August 2024 Sentiment: POSITIVE

Hyperfine, Inc. (HYPR) came out with a quarterly loss of $0.14 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.15 per share a year ago.

Hyperfine's (HYPR) Swoop System Gets New FDA-Cleared Software
zacks.com18 July 2024 Sentiment: POSITIVE

Hyperfine (HYPR) announces the receipt of FDA clearance for its ninth-generation AI-powered Swoop system software.

Hyperfine (HYPR) Inks New Partnerships to Expand in Europe
zacks.com11 July 2024 Sentiment: POSITIVE

Hyperfine (HYPR) announces that it has signed agreements with experienced and accomplished distributors in Germany, Austria, Switzerland, and key Nordic markets for its Swoop, a portable MRI system.

Hyperfine, Inc. (HYPR) Q1 2024 Earnings Call Transcript
Seeking Alpha13 May 2024 Sentiment: NEUTRAL

Hyperfine, Inc. (NASDAQ: HYPR) will be holding its Q1 2024 Earnings Conference Call on May 13, 2024 at 4:30 PM ET. The call will be led by Marissa Bych from Gilmartin Group, Investor Relations, Maria Sainz, President and CEO, and Brett Hale, CAO and CFO. Xuyang Li from Jefferies will also be present. Good afternoon, and thank you for joining the Hyperfine's Q1 2024 Earnings Conference Call. All participants are currently in listen-only mode.

Hyperfine, Inc. (HYPR) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research13 May 2024 Sentiment: POSITIVE

Hyperfine, Inc. (HYPR) reported a quarterly loss of $0.14 per share, which was in line with the Zacks Consensus Estimate and an improvement from the loss of $0.17 per share in the same quarter last year.

Will Hyperfine, Inc. (HYPR) Report Negative Earnings Next Week? What You Should Know
Zacks Investment Research06 May 2024 Sentiment: NEGATIVE

Hyperfine (HYPR) lacks the necessary ingredients for a potential earnings beat in its upcoming report. Be sure to have the key expectations in mind.

What type of business is Hyperfine?

Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.

What sector is Hyperfine in?

Hyperfine is in the Healthcare sector

What industry is Hyperfine in?

Hyperfine is in the Medical Devices industry

What country is Hyperfine from?

Hyperfine is headquartered in United States

When did Hyperfine go public?

Hyperfine initial public offering (IPO) was on 28 January 2021

What is Hyperfine website?

https://hyperfine.io

Is Hyperfine in the S&P 500?

No, Hyperfine is not included in the S&P 500 index

Is Hyperfine in the NASDAQ 100?

No, Hyperfine is not included in the NASDAQ 100 index

Is Hyperfine in the Dow Jones?

No, Hyperfine is not included in the Dow Jones index

When was Hyperfine the previous earnings report?

No data

When does Hyperfine earnings report?

The next expected earnings date for Hyperfine is 08 November 2024